©2010 Baishideng.
World J Gastroenterol. Jan 21, 2010; 16(3): 359-364
Published online Jan 21, 2010. doi: 10.3748/wjg.v16.i3.359
Published online Jan 21, 2010. doi: 10.3748/wjg.v16.i3.359
Table 2 TaqMan® primer and probe sequences of NOD2 and IL23R assays
| Marker | Primers | Probes |
| NOD2 | ||
| rs2066844 | 5'-TTCCTGGCAGGGCTGTTGTC | TET-CCTGCTCTGGCGCCAGGCC |
| 5'-AGTGGAAGTGCTTGCGGAGG | FAM-CCTGCTCCGGCGCCAGGC | |
| rs2066845 | 5'-ACTCACTGACACTGTCTGTTGACTCT | TET-TTCAGATTCTGGCGCAACAGAGTGGGT |
| 5'-AGCCACCTCAAGCTCTGGTG | FAM-TTTTCAGATTCTGGGGCAACAGAGTGGGT | |
| rs2066847 | 5'-CCAGGTTGTCCAATAACTGCATC | VIC-TGCAGGCCCCTTG |
| 5'-CCTTACCAGACTTCCAGGATGGT | FAM-CTGCAGGCCCTTG | |
| IL23R | ||
| rs11209026 | 5'-CGTCTTTGCTGTTATGTTGTCAATTCTT | VIC-CAGATCATTCCAAACTG |
| 5'-AGAAAACAGAAATTCTGCAAAAACCTACC | FAM-ACAGATCATTCCGAACTG | |
-
Citation: Sventoraityte J, Zvirbliene A, Franke A, Kwiatkowski R, Kiudelis G, Kupcinskas L, Schreiber S.
NOD2 ,IL23R andATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease. World J Gastroenterol 2010; 16(3): 359-364 - URL: https://www.wjgnet.com/1007-9327/full/v16/i3/359.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i3.359